Predictive factors of downstaging of hepatocellular carcinoma beyond the milan criteria treated with intra-arterial therapies

CardioVascular and Interventional Radiology

Volumn 36, Issue 2, 2013, Pages 433-439

  Bova, Valentina ^a   Miraglia, Roberto ^a   Maruzzelli, Luigi ^a   Vizzini, Giovanni Battista ^a   Luca, Angelo ^a  

^a MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

Author keywords

Chemoembolization; Hepatocellular carcinoma (HCC); Liver hepatic

Indexed keywords

ALPHA FETOPROTEIN; EPIRUBICIN; GELFOAM; IODINATED POPPYSEED OIL;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; CANCER INFILTRATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FACTORIAL ANALYSIS; FEMALE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; TRANSARTERIAL CHEMOEMBOLIZATION; TRANSARTERIAL EMBOLIZATION; TRANSARTERIAL OILY CHEMOEMBOLIZATION; TREATMENT RESPONSE;

ADULT; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; IOHEXOL; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MEGLUMINE; MIDDLE AGED; NEOPLASM STAGING; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME; TRIIODOBENZOIC ACIDS;

EID: 84875208850     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-012-0458-1     Document Type: Article

References (18)

1. Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334(11):693-699
2. Bruix J, Sherman M (2005) Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 42(5):1208-1236
3. Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362(9399):1907-1917
4. Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429-442
5. Sen G, Rai R, Manas DM (2003) Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg 90:1022
6. Yao FY (2006) Expanding criteria for hepatocellular carcinoma: down-staging with a view to liver transplantation. Semin Liver Dis 26:239-247
7. Yao FY, Ferrell L, Bass NM et al (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33(6):1394-1403
8. Yao FY, Kerlan RK Jr, Hirose R et al (2008) Excellent outcome following downstaging of HCC prior to liver transplantation: an intention-to-treat analysis. Hepatology 48:819-827
9. Ravaioli M, Grazi GL, Piscaglia F et al (2008) Liver transplantation for HCC: results of downstaging in patients initially outside the Milan selection criteria. Am J Transplant 8:2547-2557
10. Graziadei IW, Sandmueller H, Waldenberger P et al (2003) Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 9:557-563
11. Barakat O, Wood PR, Ozaki CF et al (2010) Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation: an intention-to-treat analysis. Liver Transpl 16:289-299
12. Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30:52-60
13. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020-1022
14. Mazzaferro V, Llovet J, Miceli R et al (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10:35-43
15. Brown DB, Cardella JF, Sacks D et al (2009) Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol 20(7 suppl):S219-S226
16. Gordon-Weeks AN, Snaith A, Petrinic T et al (2011) Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria. Br J Surg 98(9):1201-1208
17. Lammer J, Malagari K, Vogl T et al (2010) Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33(1):41-52
18. Burrel M, Reig M, Forner A et al (2012) Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using DC beads. Implications for clinical practice and trial design. J Hepatol 56(6):1330-1335